In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. This podcast is sponsored by argenx. Visit <a href= "https://www.vyvgarthcp.com/">www.vyvgarthcp.com</a> for more information.

Neurology Today in 5

OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the latest issue.